Stress resilience in patients with drug-resistant TB

被引:0
作者
Nur, N. [1 ]
Sharif, A. B. [1 ,2 ,3 ]
Mitra, D. K. [1 ]
机构
[1] North South Univ, Dept Publ Hlth, Dhaka, Bangladesh
[2] North South Univ, Global Hlth Inst, Dhaka, Bangladesh
[3] North South Univ, NSU Global Hlth Inst, Dept Publ Hlth, Plot 15,Block B, Dhaka 1229, Bangladesh
关键词
pulmonary tuberculosis; multidrug-resis-tant; pre-extensive drug-resistant; stress resilience; TUBERCULOSIS; DEPRESSION;
D O I
10.5588/ijtld.22.0648
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BACKGROUND: The worldwide increase in drug -resis-tant pulmonary TB (DR-PTB) has a significant impact on patient's physical and mental health. The objective of this study is to assess the stress resilience of DR-PTB patients along with the factors associated with it.METHODS: A total of 385 adult DR-PTB patients with multidrug-resistant (MDR) and pre-extensive drug -resistant (pre-XDR) TB admitted to the National Institute of Diseases of the Chest Hospital (Dhaka, Bangladesh) between January 2020 and March 2021 were conveniently recruited. Resilience data were collected using a validated Stress Resilience Scale (RS 25) questionnaire.RESULTS: The mean resilience scores were significantly higher for patients with MDR-PTB than those with pre-XDR-PTB (P = 0.02). A majority of the MDR-PTB (77.0%) and pre-XDR-PTB (65.1%) patients belonged to the <45 years age group. Multiple linear regression revealed that sex (P < 0.001), level of education (P < 0.001), employment status (P = 0.003) and presence of asthma (P = 0.010) were significantly associated with stress resilience.CONCLUSION: We observed that stress resilience sig-nificantly differed between patients with MDR-PTB and those with pre-XDR-PTB based on sociodemographic characteristics.
引用
收藏
页码:551 / +
页数:7
相关论文
共 50 条
  • [21] Multidrug-resistant and extensively drug-resistant tuberculosis
    Chiang, C-Y.
    Yew, W. W.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2009, 13 (03) : 304 - 311
  • [22] Pediatric Drug-resistant Tuberculosis in Madrid
    Santiago, Begona
    Baquero-Artigao, Fernando
    Mejias, Asuncion
    Blazquez, Daniel
    Soledad Jimenez, Maria
    Jose Mellado-Pena, Maria
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (04) : 345 - 350
  • [23] Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline
    Kaniga, K.
    Lounis, N.
    Zhuo, S.
    Bakare, N.
    Andries, K.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2022, 26 (06) : 571 - 573
  • [24] Once-a-week tigecycline for the treatment of drug-resistant TB
    Deshpande, Devyani
    Magombedze, Gesham
    Srivastava, Shashikant
    Bendet, Paula
    Lee, Pooi S.
    Cirrincione, Kayle N.
    Martin, Katherine R.
    Dheda, Keertan
    Gumbo, Tawanda
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (06) : 1607 - 1617
  • [25] Prevention care cascade in people exposed to drug-resistant TB
    van de Water, B. J.
    Vance, A. J.
    Amangoaela, L. R.
    Otha, M. B.
    Becerra, M. C.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2020, 24 (12) : 1305 - 1306
  • [26] Addressing bedaquiline treatment interruptions in the treatment of drug-resistant TB
    Kambili, C.
    Rossenu, S.
    Hoetelmans, R. M. W.
    Birmingham, E.
    Bakare, N.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2022, 26 (07) : 671 - 677
  • [27] Drug-resistant tuberculosis
    Long, Richard
    Avendano, Monica
    Kunimoto, Dennis
    CANADIAN RESPIRATORY JOURNAL, 2013, 20 : 65A - 77A
  • [28] HIV remains a deadly companion to drug-resistant TB in Ukraine
    Dahl, V. N.
    Butova, T.
    Kuzhko, M.
    Sapelnik, N.
    Borysova, O.
    Pedersen, O. S.
    Butov, D.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2024, 28 (08) : 400 - 402
  • [29] Prevalence of drug-resistant Mycobacterium tuberculosis in patients under intermittent or daily treatment
    Alvarez, Tomas Aiza
    Rodrigues, Marcelo Palmeira
    de Assis Viegas, Carlos Alberto
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2009, 35 (06) : 555 - 560
  • [30] Risk Factors for Poor Outcomes Among Patients with Extensively Drug-Resistant Tuberculosis (XDR-TB): A Scoping Review
    Varshney, Karan
    Anaele, Beverly
    Molaei, Matthew
    Frasso, Rosemary
    Maio, Vittorio
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 5429 - 5448